Invenomic Capital Management LP

Q2 2026 13F-HR Holdings

Location
Boston, MA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
116
Total value ($000)
$1,674,265
Net value change ($000)
-505,252 (-23.2%)
New positions
21
Sold out positions
54
Turnover %
52.2%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BDX 41,341 NEW
CHTR 40,162 NEW
SPSC 35,002 238.1%
UHS 30,401 91.8%
INTU 27,825 NEW
HURN 19,842 NEW
PRGS 17,167 NEW
GEHC 14,917 NEW
DLO 14,818 447.4%
CMCSA 12,950 515.5%
Top Reduces (Value $000, Stocks/ETFs)
CHRD -73,235 -100.0%
TFX -52,165 -100.0%
AKAM -46,587 -100.0%
WIX -35,194 -92.1%
RNG -30,210 -100.0%
ACHC -27,655 -100.0%
RAMP -26,816 -100.0%
SOLV -26,195 -100.0%
SNAP -24,200 -100.0%
IOVA -23,651 -79.3%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 302 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type